Windgap Medical

Windgap Medical is a private, commercial-stage platform company specializing in advanced autoinjector systems for complex drug formulations. Its core technology platforms enable automated mixing and delivery of lyophilized powders, sequential delivery of two liquids, and administration of high-viscosity/large-volume drugs, addressing significant unmet needs in biopharma. With a leadership team boasting over 120 years of combined industry experience, the company has secured regulatory approvals for over 30 combination products and is trusted by five of the top ten biopharmaceutical firms. Windgap positions itself as a critical device partner, helping pharmaceutical companies bring complex injectables to market faster and more sustainably.

Multi-platform autoinjector systems for automated powder reconstitution, sequential liquid delivery, and high-viscosity/large-volume (up to 10mL, 5000+ cP) subcutaneous injections.

Windgap competes in the advanced autoinjector market against large drug delivery companies like West Pharmaceutical Services, Gerresheimer, and SHL Medical, as well as other specialized startups. Its differentiation lies in its focused expertise on the most challenging formulations, particularly automated wet-dry reconstitution, which is a less crowded niche.